Market Tracker

05/04 5:32am ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.64
Delayed Data
As of May 03
 0.00 / 0.00%
Today’s Change
2.80
Today|||52-Week Range
11.12
+11.68%
Year-to-Date

Today’s Trading

Previous close5.64
Today’s openn.a.
Day’s range5.61 - 5.88
Volume22,476
Average volume (3 months)1,734,100
Market cap$630.7M
Dividend yield--
Data as of 05/03/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)+22.77%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book7.21

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...0.000.00%
MNKDMannkind Corp+0.03+2.07%
CPXXCelator Pharmaceutic...0.000.00%
EGRXEagle Pharmaceutical...+1.30+3.28%
Data as of 05/03/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts